Colombian immunologist doctor. While studying he spent several seasons at Yale University, in the United States, where he completed his studies. The first topic of his research is genetic markers and shows that although the etiology of infectious diseases is considered external, there is a genetic predisposition to contract them. In 1979, it identifies the genetic predisposition of tuberculosis, leprosy and rheumatic fever. The scope of this discovery is that at birth the genetic marker of the patient is detected, it can be subjected to a process of immunization or to reduce the risk of infection and infection. It seeks to produce a synthetic chemical vaccine against tuberculosis, then extends its research to leprosy and malaria. In 1994, after years of field research, he managed to create a synthetic vaccine against malaria effective even in endemic areas of Central Africa. Give the patent to the WHO so that it can be distributed at minimal cost. He is a pathology instructor at the National University, an adjunct professor at the Rockefeller University in the United States and a visiting professor at the Karolinska Institute in Sweden.
Learn more about your health and well-being at Pharmamedic.
